Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-28 to 2024-10-21
Current total value of award: $56516.1
Description: 4565988708!XOLAIR 300 MG/2 ML SYRINGE 2ML